DF/HCC Is a Research Consortium

that provides shared resources and a collaborative environment for over 1,100 cancer researchers at 7 Harvard institutions. Learn more about DF/HCC here

Research

Information for DF/HCC members and collaborators

Core Facilities

Shared resources available to DF/HCC members

Community

Resources and initiatives for Massachusetts communities

Training

Opportunities for training and career enhancement

Clinical Trials

Clinical Investigator Support and Trial Search Tool

Patient seeking a trialClinical Research Team

Center Funding & Announcements

  • April 24, 2024 – Announcements

    Cancer Neuroscience T32 Course Series Updates

    Recordings are available at these links for Course #1, “Cancer Therapeutics and Neuronal Dysfunction”; and Course #2, “CART Cells for glioma immunotherapy”.   Please contact me at sschwaninger@mgb.org with access issues.

  • April 24, 2024 – Announcements

    Request for Trainee Applications: T32 Training Grant in Cancer Neuroscience

    The Neuro-Oncology Program at Dana-Farber/Harvard Cancer Center (DF/HCC), the Department of Neurobiology at Harvard Medical School, and the Department of Neurology at Brigham and Women’s Hospital are seeking…

  • April 19, 2024 – Announcements

    REGISTER | 05/17 David Livingston Memorial Symposium

    Please join us on May 17 from 11am-12pm at the Dana-Farber Jimmy Fund Auditorium for the second annual David M. Livingston Memorial Symposium with a focus on "Cancer Resistant Mice from Random Germline Mutagenesis."

  • April 16, 2024 – Announcements

    2024 DF/HCC Microbiome Symposium Workshop

    DF/HCC & the Harvard Chan Microbiome in Public Health Center (HCMPH) invite you to attend the 2024 DF/HCC Microbiome Symposium Workshop on May 14, 2024.

See more news